Rubric Capital Management (New York)’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Rubric Capital Management (New York)’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,747,401	Closed	-$5.42M	–	87
2021 Q4	$5.42M	Buy	+1,747,401	New	+$5.88M	0.26%	52
2021 Q1	–	Sell	-3,516,124	Closed	-$14.8M	–	81
2020 Q4	$14.8M	Sell	3,516,124 -483,876	-12%	-$1.86M	1.09%	35
2020 Q3	$14.9M	Hold	4,000,000	–	–	1.39%	30
2020 Q2	$17.4M	Buy	4,000,000 +217,654	+6%	+$978K	2.01%	24
2020 Q1	$14.3M	Buy	3,782,346 +1,192,058	+46%	+$5.86M	2.26%	20
2019 Q4	$16.4M	Hold	2,590,288	–	–	1.85%	23
2019 Q3	$10.9M	Buy	2,590,288 +298,156	+13%	+$1.27M	1%	29
2019 Q2	$10.7M	Hold	2,292,132	–	–	0.84%	35
2019 Q1	$12.1M	Buy	2,292,132 +296,173	+15%	+$1.35M	1.13%	32
2018 Q4	$7.38M	Buy	+1,995,959	New	+$7.01M	0.91%	31

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Rubric Capital Management (New York)'s BDSI Position: Q1 2022 in Review

Rubric Capital Management (New York) sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 1,747,401 shares — an estimated $5.42M sold.

Rubric Capital Management (New York) first reported a position in BDSI in Q4 2018 and held it in 10 quarters. The position peaked at $17.4M in Q2 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Rubric Capital Management (New York) reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Rubric Capital Management (New York) sold 1,747,401 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $5.42M.
Rubric Capital Management (New York) first reported a position in BioDelivery Sciences International, Inc. in Q4 2018 and held it in 10 quarters.
Rubric Capital Management (New York)'s BioDelivery Sciences International, Inc. position peaked at $17.4M in Q2 2020.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2022, filed 13 May 2022.